NCT05672680View on ClinicalTrials.gov

Transabdominal Plane (TAP) Blocks for Inguinal Hernia Repairs

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

December 9, 2019

Primary Completion Date

August 3, 2023

Study Completion Date

August 3, 2023

Conditions

Inguinal Hernia

Interventions

DRUG

0.25% Bupivacaine

received during TAP block

DRUG

Placebo

placebo equivalent

PROCEDURE

TAP block

The intervention is a transabdominal plane (TAP) block given in the abdomen to block pain receptors on nerves -during surgery can presumably decrease postoperative pain. Currently, TAP blocks are approved for use and performed based on surgeon preference (e.g. some surgeons perform them on every case, others variably, etc.).

Trial Locations (1)

10029

Mount Sinai Hospital, New York

All Listed Sponsors

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT05672680 - Transabdominal Plane (TAP) Blocks for Inguinal Hernia Repairs | Biotech Hunter | Biotech Hunter